Antibacterial Coatings Market for Medical Implants By Material (Metallic Coatings, Non-Metallic Coatings), By Type (Cardiac Implants, Orthopedic Implants, Dental Implants, Neurological Implants, Other Implants): Global Opportunity Analysis and Industry Forecast, 2020-2030

The anti-bacterial coatings market for medical implants was valued at $234.42 million in 2020, and is estimated to reach $1,072.27 million by 2030, growing at a CAGR of 16.4% from 2021 to 2030.

Anti-bacterial coatings are materials that reduce implants-related infections in patients by inhibiting bacterial adhesion, colonization, and proliferation of bacteria on the implant surface and into the surrounding tissues. Medical implants are highly susceptible to infection and may result to risk in surgery. Therefore, treatment with anti-bacterial coatings provide protection against pathologically relevant strains of bacteria.

Growth of the anti-bacterial coatings market for medical implants is majorly driven by alarming rise in prevalence of implant associated infections, technological advancements in anti-bacterial coatings, and high adoption of cardiovascular & orthopedics implants. Moreover, increase in geriatric population and rise in burden of bone related disorders and cardiovascular diseases across the globe further drives the market growth. In addition, the U.S. has one of the most robust healthcare system globally. There has been surge in healthcare investment in the country, owing to the COVID-19 outbreak. The preference for anti-bacterial coated medical equipment in the U.S. is increasing due to the various initiatives taken by the government as well as the hospitals in the country to prevent nosocomial infection. These aforementioned factors contribute towards the growth of the market.  Conversely, increase in awareness about implantation surgeries, development of effective anti-bacterial coating for medical implants, and rise in demand for better healthcare facilities are expected to provide opportunities for the market growth during the forecast period. However, high cost of implantation procedures and raw materials involved in the manufacturing of coatings restricts the market growth.

Moreover, key players such as Hydromer Inc., Covalon Technologies Ltd., and AST Product, provide numerous anti-bacterial coatings products to contribute toward the market growth.

Cardiovascular diseases (CVDs) are the leading cause of death across the globe, with an estimate of 17.9 million fatalities each year. According to report of the British Heart Foundation, in 2021, 7.6 million people were diagnosed with heart & circulatory diseases, causing about 25% death in UK. Thus, rise in use of anti-bacterial coatings in cardiac implants products, which are used during cardiac surgeries, contributes toward the growth of anti-bacterial coatings market.

The anti-bacterial coating market for medical implants is segmented on the basis of material, product type, and region. By material, it is bifurcated into metallic and non-metallic coatings. Metallic coatings are further segmented into silver coatings, copper coatings, and other coatings. Non-metallic coatings segment is further divided into polymeric coatings and organic coatings. On the basis of type, the market is divided into orthopedic, dental, neurovascular, cardiac, and other implants. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global anti-bacterial coatings market are Aap Implantate AG, AST Products, Inc., BioCote Ltd., Covalon Technologies Ltd., DOT GmbH, Harland Medical Systems Inc., Hydromer, Inc., Secoa Metal Finishing, Sciessent LLC, and Specialty Coating Systems, Inc.

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the antibacterial coatings market analysis from 2020 to 2030 to identify the prevailing antibacterial coatings market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the antibacterial coatings market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global antibacterial coatings market trends, key players, market segments, application areas, and market growth strategies.

By Material

● Metallic Coatings

● Non-Metallic Coatings

By Type

● Cardiac Implants

● Orthopedic Implants

● Dental Implants

● Neurological Implants

● Other Implants

By Region

● North America

○ U.S.

○ Canada

○ Mexico

● Europe

○ Germany

○ France

○ U.K.

○ Italy

○ Spain

○ Rest of Europe

● Asia-Pacific

○ Japan

○ China

○ India

○ Australia

○ South Korea

○ Rest of Asia-Pacific

● LAMEA

○ Brazil

○ Saudi Arabia

○ South Africa

○ Rest of LAMEA

● Key Market Players

○ Secoa Technolog

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Metallic Coatings

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Non-Metallic Coatings

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Cardiac Implants

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Orthopedic Implants

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Dental Implants

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Neurological Implants

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

5.6 Other Implants

5.6.1 Key market trends, growth factors and opportunities

5.6.2 Market size and forecast, by region

5.6.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key trends and opportunities

6.2.2 North America Market size and forecast, by Material

6.2.3 North America Market size and forecast, by Type

6.2.4 North America Market size and forecast, by country

6.2.4.1 U.S.

6.2.4.1.1 Market size and forecast, by Material

6.2.4.1.2 Market size and forecast, by Type

6.2.4.2 Canada

6.2.4.2.1 Market size and forecast, by Material

6.2.4.2.2 Market size and forecast, by Type

6.2.4.3 Mexico

6.2.4.3.1 Market size and forecast, by Material

6.2.4.3.2 Market size and forecast, by Type

6.3 Europe

6.3.1 Key trends and opportunities

6.3.2 Europe Market size and forecast, by Material

6.3.3 Europe Market size and forecast, by Type

6.3.4 Europe Market size and forecast, by country

6.3.4.1 Germany

6.3.4.1.1 Market size and forecast, by Material

6.3.4.1.2 Market size and forecast, by Type

6.3.4.2 France

6.3.4.2.1 Market size and forecast, by Material

6.3.4.2.2 Market size and forecast, by Type

6.3.4.3 U.K.

6.3.4.3.1 Market size and forecast, by Material

6.3.4.3.2 Market size and forecast, by Type

6.3.4.4 Italy

6.3.4.4.1 Market size and forecast, by Material

6.3.4.4.2 Market size and forecast, by Type

6.3.4.5 Spain

6.3.4.5.1 Market size and forecast, by Material

6.3.4.5.2 Market size and forecast, by Type

6.3.4.6 Rest of Europe

6.3.4.6.1 Market size and forecast, by Material

6.3.4.6.2 Market size and forecast, by Type

6.4 Asia-Pacific

6.4.1 Key trends and opportunities

6.4.2 Asia-Pacific Market size and forecast, by Material

6.4.3 Asia-Pacific Market size and forecast, by Type

6.4.4 Asia-Pacific Market size and forecast, by country

6.4.4.1 Japan

6.4.4.1.1 Market size and forecast, by Material

6.4.4.1.2 Market size and forecast, by Type

6.4.4.2 China

6.4.4.2.1 Market size and forecast, by Material

6.4.4.2.2 Market size and forecast, by Type

6.4.4.3 India

6.4.4.3.1 Market size and forecast, by Material

6.4.4.3.2 Market size and forecast, by Type

6.4.4.4 Australia

6.4.4.4.1 Market size and forecast, by Material

6.4.4.4.2 Market size and forecast, by Type

6.4.4.5 South Korea

6.4.4.5.1 Market size and forecast, by Material

6.4.4.5.2 Market size and forecast, by Type

6.4.4.6 Rest of Asia-Pacific

6.4.4.6.1 Market size and forecast, by Material

6.4.4.6.2 Market size and forecast, by Type

6.5 LAMEA

6.5.1 Key trends and opportunities

6.5.2 LAMEA Market size and forecast, by Material

6.5.3 LAMEA Market size and forecast, by Type

6.5.4 LAMEA Market size and forecast, by country

6.5.4.1 Brazil

6.5.4.1.1 Market size and forecast, by Material

6.5.4.1.2 Market size and forecast, by Type

6.5.4.2 Saudi Arabia

6.5.4.2.1 Market size and forecast, by Material

6.5.4.2.2 Market size and forecast, by Type

6.5.4.3 South Africa

6.5.4.3.1 Market size and forecast, by Material

6.5.4.3.2 Market size and forecast, by Type

6.5.4.4 Rest of LAMEA

6.5.4.4.1 Market size and forecast, by Material

6.5.4.4.2 Market size and forecast, by Type

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Key developments

8.1 AAP IMPLANTATE AG

8.1.1 Company overview

8.1.2 Company snapshot

8.1.3 Operating business segments

8.1.4 Product portfolio

8.1.5 Business performance

8.1.6 Key strategic moves and developments

8.2 AST PRODUCTS INC.

8.2.1 Company overview

8.2.2 Company snapshot

8.2.3 Operating business segments

8.2.4 Product portfolio

8.2.5 Business performance

8.2.6 Key strategic moves and developments

8.3 BIOCOTE LTD.

8.3.1 Company overview

8.3.2 Company snapshot

8.3.3 Operating business segments

8.3.4 Product portfolio

8.3.5 Business performance

8.3.6 Key strategic moves and developments

8.4 COVALON TECHNOLOGIES, LTD.

8.4.1 Company overview

8.4.2 Company snapshot

8.4.3 Operating business segments

8.4.4 Product portfolio

8.4.5 Business performance

8.4.6 Key strategic moves and developments

8.5 DOT GMBH

8.5.1 Company overview

8.5.2 Company snapshot

8.5.3 Operating business segments

8.5.4 Product portfolio

8.5.5 Business performance

8.5.6 Key strategic moves and developments

8.6 HARLAND MEDICAL SYSTEMS, INC.

8.6.1 Company overview

8.6.2 Company snapshot

8.6.3 Operating business segments

8.6.4 Product portfolio

8.6.5 Business performance

8.6.6 Key strategic moves and developments

8.7 HYDROMER INC.

8.7.1 Company overview

8.7.2 Company snapshot

8.7.3 Operating business segments

8.7.4 Product portfolio

8.7.5 Business performance

8.7.6 Key strategic moves and developments

8.8 SCIESSENT LLC.

8.8.1 Company overview

8.8.2 Company snapshot

8.8.3 Operating business segments

8.8.4 Product portfolio

8.8.5 Business performance

8.8.6 Key strategic moves and developments

8.9 SPECIALTY COATING SYSTEMS, INC.

8.9.1 Company overview

8.9.2 Company snapshot

8.9.3 Operating business segments

8.9.4 Product portfolio

8.9.5 Business performance

8.9.6 Key strategic moves and developments

8.10 Secoa Technology

8.10.1 Company overview

8.10.2 Company snapshot

8.10.3 Operating business segments

8.10.4 Product portfolio

8.10.5 Business performance

8.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 2. ANTIBACTERIAL COATINGS MARKET SIZE, FOR METALLIC COATINGS, BY REGION, 2020-2030 ($MILLION)

TABLE 3. ANTIBACTERIAL COATINGS MARKET FOR METALLIC COATINGS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 4. ANTIBACTERIAL COATINGS MARKET SIZE, FOR NON-METALLIC COATINGS, BY REGION, 2020-2030 ($MILLION)

TABLE 5. ANTIBACTERIAL COATINGS MARKET FOR NON-METALLIC COATINGS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 6. GLOBAL ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 7. ANTIBACTERIAL COATINGS MARKET SIZE, FOR CARDIAC IMPLANTS, BY REGION, 2020-2030 ($MILLION)

TABLE 8. ANTIBACTERIAL COATINGS MARKET FOR CARDIAC IMPLANTS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 9. ANTIBACTERIAL COATINGS MARKET SIZE, FOR ORTHOPEDIC IMPLANTS, BY REGION, 2020-2030 ($MILLION)

TABLE 10. ANTIBACTERIAL COATINGS MARKET FOR ORTHOPEDIC IMPLANTS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 11. ANTIBACTERIAL COATINGS MARKET SIZE, FOR DENTAL IMPLANTS, BY REGION, 2020-2030 ($MILLION)

TABLE 12. ANTIBACTERIAL COATINGS MARKET FOR DENTAL IMPLANTS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 13. ANTIBACTERIAL COATINGS MARKET SIZE, FOR NEUROLOGICAL IMPLANTS, BY REGION, 2020-2030 ($MILLION)

TABLE 14. ANTIBACTERIAL COATINGS MARKET FOR NEUROLOGICAL IMPLANTS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 15. ANTIBACTERIAL COATINGS MARKET SIZE, FOR OTHER IMPLANTS, BY REGION, 2020-2030 ($MILLION)

TABLE 16. ANTIBACTERIAL COATINGS MARKET FOR OTHER IMPLANTS, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 17. ANTIBACTERIAL COATINGS MARKET, BY REGION, 2020-2030 ($MILLION)

TABLE 18. NORTH AMERICA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 19. NORTH AMERICA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 20. NORTH AMERICA ANTIBACTERIAL COATINGS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 21. U.S. ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 22. U.S. ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 23. CANADA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 24. CANADA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 25. MEXICO ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 26. MEXICO ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 27. EUROPE ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 28. EUROPE ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 29. EUROPE ANTIBACTERIAL COATINGS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 30. GERMANY ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 31. GERMANY ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 32. FRANCE ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 33. FRANCE ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 34. U.K. ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 35. U.K. ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 36. ITALY ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 37. ITALY ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 38. SPAIN ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 39. SPAIN ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 40. REST OF EUROPE ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 41. REST OF EUROPE ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 42. ASIA-PACIFIC ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 43. ASIA-PACIFIC ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 44. ASIA-PACIFIC ANTIBACTERIAL COATINGS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 45. JAPAN ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 46. JAPAN ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 47. CHINA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 48. CHINA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 49. INDIA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 50. INDIA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 51. AUSTRALIA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 52. AUSTRALIA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 53. SOUTH KOREA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 54. SOUTH KOREA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 55. REST OF ASIA-PACIFIC ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 56. REST OF ASIA-PACIFIC ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 57. LAMEA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 58. LAMEA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 59. LAMEA ANTIBACTERIAL COATINGS MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 60. BRAZIL ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 61. BRAZIL ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 62. SAUDI ARABIA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 63. SAUDI ARABIA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 64. SOUTH AFRICA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 65. SOUTH AFRICA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 66. REST OF LAMEA ANTIBACTERIAL COATINGS MARKET, BY MATERIAL, 2020-2030 ($MILLION)

TABLE 67. REST OF LAMEA ANTIBACTERIAL COATINGS MARKET, BY TYPE, 2020-2030 ($MILLION)

TABLE 68.AAP IMPLANTATE AG: COMPANY SNAPSHOT

TABLE 69.AAP IMPLANTATE AG: OPERATING SEGMENTS

TABLE 70.AAP IMPLANTATE AG: PRODUCT PORTFOLIO

TABLE 71.AAP IMPLANTATE AG: NET SALES,

TABLE 72.AAP IMPLANTATE AG: KEY STRATERGIES

TABLE 73.AST PRODUCTS INC.: COMPANY SNAPSHOT

TABLE 74.AST PRODUCTS INC.: OPERATING SEGMENTS

TABLE 75.AST PRODUCTS INC.: PRODUCT PORTFOLIO

TABLE 76.AST PRODUCTS INC.: NET SALES,

TABLE 77.AST PRODUCTS INC.: KEY STRATERGIES

TABLE 78.BIOCOTE LTD.: COMPANY SNAPSHOT

TABLE 79.BIOCOTE LTD.: OPERATING SEGMENTS

TABLE 80.BIOCOTE LTD.: PRODUCT PORTFOLIO

TABLE 81.BIOCOTE LTD.: NET SALES,

TABLE 82.BIOCOTE LTD.: KEY STRATERGIES

TABLE 83.COVALON TECHNOLOGIES, LTD.: COMPANY SNAPSHOT

TABLE 84.COVALON TECHNOLOGIES, LTD.: OPERATING SEGMENTS

TABLE 85.COVALON TECHNOLOGIES, LTD.: PRODUCT PORTFOLIO

TABLE 86.COVALON TECHNOLOGIES, LTD.: NET SALES,

TABLE 87.COVALON TECHNOLOGIES, LTD.: KEY STRATERGIES

TABLE 88.DOT GMBH: COMPANY SNAPSHOT

TABLE 89.DOT GMBH: OPERATING SEGMENTS

TABLE 90.DOT GMBH: PRODUCT PORTFOLIO

TABLE 91.DOT GMBH: NET SALES,

TABLE 92.DOT GMBH: KEY STRATERGIES

TABLE 93.HARLAND MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT

TABLE 94.HARLAND MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS

TABLE 95.HARLAND MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO

TABLE 96.HARLAND MEDICAL SYSTEMS, INC.: NET SALES,

TABLE 97.HARLAND MEDICAL SYSTEMS, INC.: KEY STRATERGIES

TABLE 98.HYDROMER INC.: COMPANY SNAPSHOT

TABLE 99.HYDROMER INC.: OPERATING SEGMENTS

TABLE 100.HYDROMER INC.: PRODUCT PORTFOLIO

TABLE 101.HYDROMER INC.: NET SALES,

TABLE 102.HYDROMER INC.: KEY STRATERGIES

TABLE 103.SCIESSENT LLC.: COMPANY SNAPSHOT

TABLE 104.SCIESSENT LLC.: OPERATING SEGMENTS

TABLE 105.SCIESSENT LLC.: PRODUCT PORTFOLIO

TABLE 106.SCIESSENT LLC.: NET SALES,

TABLE 107.SCIESSENT LLC.: KEY STRATERGIES

TABLE 108.SPECIALTY COATING SYSTEMS, INC.: COMPANY SNAPSHOT

TABLE 109.SPECIALTY COATING SYSTEMS, INC.: OPERATING SEGMENTS

TABLE 110.SPECIALTY COATING SYSTEMS, INC.: PRODUCT PORTFOLIO

TABLE 111.SPECIALTY COATING SYSTEMS, INC.: NET SALES,

TABLE 112.SPECIALTY COATING SYSTEMS, INC.: KEY STRATERGIES

TABLE 113.SECOA TECHNOLOGY: COMPANY SNAPSHOT

TABLE 114.SECOA TECHNOLOGY: OPERATING SEGMENTS

TABLE 115.SECOA TECHNOLOGY: PRODUCT PORTFOLIO

TABLE 116.SECOA TECHNOLOGY: NET SALES,

TABLE 117.SECOA TECHNOLOGY: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.ANTIBACTERIAL COATINGS MARKET SEGMENTATION

FIGURE 2.ANTIBACTERIAL COATINGS MARKET,2020-2030

FIGURE 3.ANTIBACTERIAL COATINGS MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.ANTIBACTERIAL COATINGS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.ANTIBACTERIAL COATINGS MARKET,BY MATERIAL,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF METALLIC COATINGS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NON-METALLIC COATINGS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 15.ANTIBACTERIAL COATINGS MARKET,BY TYPE,2020(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CARDIAC IMPLANTS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DENTAL IMPLANTS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF NEUROLOGICAL IMPLANTS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHER IMPLANTS ANTIBACTERIAL COATINGS MARKET,2020-2030(%)

FIGURE 21.ANTIBACTERIAL COATINGS MARKET BY REGION,2020

FIGURE 22.U.S. ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 23.CANADA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 24.MEXICO ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 25.GERMANY ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 26.FRANCE ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 27.U.K. ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 28.ITALY ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 29.SPAIN ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 30.REST OF EUROPE ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 31.JAPAN ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 32.CHINA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 33.INDIA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 34.AUSTRALIA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 35.SOUTH KOREA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 36.REST OF ASIA-PACIFIC ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 37.BRAZIL ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 38.SAUDI ARABIA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 39.SOUTH AFRICA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 40.REST OF LAMEA ANTIBACTERIAL COATINGS MARKET,2020-2030($MILLION)

FIGURE 41. TOP WINNING STRATEGIES, BY YEAR

FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 45.COMPETITIVE DASHBOARD

FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 47.AAP IMPLANTATE AG.: NET SALES ,($MILLION)

FIGURE 48.AST PRODUCTS INC..: NET SALES ,($MILLION)

FIGURE 49.BIOCOTE LTD..: NET SALES ,($MILLION)

FIGURE 50.COVALON TECHNOLOGIES, LTD..: NET SALES ,($MILLION)

FIGURE 51.DOT GMBH.: NET SALES ,($MILLION)

FIGURE 52.HARLAND MEDICAL SYSTEMS, INC..: NET SALES ,($MILLION)

FIGURE 53.HYDROMER INC..: NET SALES ,($MILLION)

FIGURE 54.SCIESSENT LLC..: NET SALES ,($MILLION)

FIGURE 55.SPECIALTY COATING SYSTEMS, INC..: NET SALES ,($MILLION)

FIGURE 56.SECOA TECHNOLOGY.: NET SALES ,($MILLION